pbs

PBS recommendations for bimekizumab, guselkumab

Eli Lilly pulls PBS application for eczema drug

New authority requirement adding to the PBS ‘clickfest’

Eli Lilly exec says slow PBS threatens clinical trials funding

Risankizumab added to PBS for psoriatic arthritis

Top 10 Dermatology Republic stories for 2024: see what made the list

‘Breakthough’ as first targeted lupus drug hits PBS

Dermatology patients to benefit from PBAC outcomes
